Celebrating our 10th anniversary – Unlock our special offer today

PMTAs: after the Reynolds approvals, which way will the FDA go next?

The FDA’s first premarket approval for a vapour product that has gone through the premarket tobacco product applications (PMTAs) process shows that it is not opposed to all vaping products, although it is also significant that it refused approval for all non-tobacco flavours (although menthol is still under review). Tobacco organisations praised the decision but said it needs to go further in future. Anti-tobacco and anti-vaping organisations’ responses ranged from guarded acceptance to continued rejection on general health or more specifically youth enticement grounds.

Read full article
I'm already a subscriber
Author default picture


This article was written by one of ECigIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual vaping markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization